BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19578014)

  • 1. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
    Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
    Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
    Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
    Jockovich ME; Bajenaru ML; Piña Y; Suarez F; Feuer W; Fini ME; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2476-82. PubMed ID: 17525173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hypoxia, a novel treatment for advanced retinoblastoma.
    Boutrid H; Jockovich ME; Murray TG; Piña Y; Feuer WJ; Lampidis TJ; Cebulla CM
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2799-805. PubMed ID: 18326690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.
    Piña Y; Houston SK; Murray TG; Boutrid H; Celdran M; Feuer W; Shi W; Hernandez E; Lampidis TJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6149-56. PubMed ID: 20702830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.
    Bajenaru ML; Piña Y; Murray TG; Cebulla CM; Feuer W; Jockovich ME; Marin Castaño ME
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2860-4. PubMed ID: 20107171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
    Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
    Piña Y; Decatur C; Murray TG; Houston SK; Lopez-Cavalcante M; Hernandez E; Celdran M; Shah N; Feuer W; Lampidis T
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):996-1002. PubMed ID: 22266512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.
    Piña Y; Boutrid H; Schefler A; Dubovy S; Feuer W; Jockovich ME; Murray TG
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1020-4. PubMed ID: 18952925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
    Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
    Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
    Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
    Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.
    Murray TG; Roth DB; O'Brien JM; Feuer W; Cicciarelli N; Markoe AM; Hernández E; Smith BJ; Windle JJ
    Arch Ophthalmol; 1996 Nov; 114(11):1385-9. PubMed ID: 8906029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
    Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
    Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.
    Houston SK; Piña Y; Murray TG; Boutrid H; Cebulla C; Schefler AC; Shi W; Celdran M; Feuer W; Merchan J; Lampidis TJ
    Clin Ophthalmol; 2011 Jan; 5():129-37. PubMed ID: 21339806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
    Piña Y; Boutrid H; Murray TG; Jager MJ; Cebulla CM; Schefler A; Ly LV; Alegret A; Celdran M; Feuer W; Jockovich ME
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2671-7. PubMed ID: 20053982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.
    Kang SJ; Durairaj C; Kompella UB; O'Brien JM; Grossniklaus HE
    Arch Ophthalmol; 2009 Aug; 127(8):1043-7. PubMed ID: 19667343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.